Target intelligence / Profile preview

Chloride voltage-gated channel 2 (ClC-2)

Target
ClC-2
Molecular classification
Ion channel, Voltage-gated chloride channel, Chloride channel (CLC) family
01

Overview

Chloride voltage-gated channel 2 (ClC-2) is a ubiquitously expressed member of the CLC family of chloride channels, encoded by the CLCN2 gene. It primarily functions as a plasma membrane chloride channel that is activated by hyperpolarization, cell swelling, and acidic pH, playing a vital role in regulating cell volume and chloride homeostasis across various tissues (UniProt ID: Q92496). In the gastrointestinal tract, ClC-2 is located on the apical membrane of epithelial cells, where its activation promotes the secretion of chloride ions and water into the lumen, making it a key target for treating chronic constipation and irritable bowel syndrome (PubMed: 19543360). Mutations in the CLCN2 gene are associated with leukoencephalopathy with ataxia, a rare neurological disorder, highlighting its importance in maintaining central nervous system integrity (StatPearls). Pharmacologically, ClC-2 is most notably targeted by lubiprostone, a bicyclic fatty acid derivative that acts as a selective activator to enhance intestinal motility without affecting systemic electrolyte levels significantly (PubChem).

Other names
CLCN2Chloride channel protein 2CIC-2Voltage-gated chloride channel 2
02

Mechanism of action

Activation of ClC-2 on the apical membrane of the gastrointestinal epithelium to increase chloride-rich fluid secretion into the intestinal lumen, thereby facilitating bowel movement.

03

Biological functions

Chloride ion transportFluid secretionCell volume regulationTransepithelial transportMembrane potential stabilizationChloride homeostasis
04

Disease associations

Chronic idiopathic constipationIrritable bowel syndrome with constipation (IBS-C)Opioid-induced constipationLeukoencephalopathy with ataxia (mutations)Epilepsy (juvenile myoclonic epilepsy association, though controversial)
05

Safety considerations

NauseaDiarrheaAbdominal distensionDyspnea (observed with lubiprostone treatment)Potential electrolyte imbalance
06

Interacting drugs

Lubiprostone

1 more in the full profile.

07

Biomarkers

CLCN2 gene mutations (for leukoencephalopathy diagnosis)

Beyond the preview

Go deeper on Chloride voltage-gated channel 2 (ClC-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride voltage-gated channel 2 (ClC-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call